Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential.
about
Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinasesDifferential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation stateThe physical association of the P2Y12 receptor with PAR4 regulates arrestin-mediated Akt activation.scFv single chain antibody variable fragment as inverse agonist of the beta2-adrenergic receptor.Partial to complete antagonism by putative antagonists at the wild-type alpha(2C)-adrenoceptor based on kinetic analyses of agonist:antagonist interactions.
P2860
Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inverse agonism at heptahelica ...... ach and therapeutic potential.
@ast
Inverse agonism at heptahelica ...... ach and therapeutic potential.
@en
type
label
Inverse agonism at heptahelica ...... ach and therapeutic potential.
@ast
Inverse agonism at heptahelica ...... ach and therapeutic potential.
@en
prefLabel
Inverse agonism at heptahelica ...... ach and therapeutic potential.
@ast
Inverse agonism at heptahelica ...... ach and therapeutic potential.
@en
P2860
P1476
Inverse agonism at heptahelica ...... ach and therapeutic potential.
@en
P2093
P2860
P356
10.1111/J.1472-8206.2000.TB00395.X
P577
2000-03-01T00:00:00Z